Walgreens will stock the Auvi-Q as an EpiPen shortage has left some pharmacies unable to fill prescriptions of the lifesaving allergy treatment, leaving some parents scrambling.
Like EpiPen, the Auvi-Q delivers epinephrine to treat severe allergic reactions. The little rectangular auto-injector walks people through its use. Drugmaker Kaleo’s partnership with Walgreens will be once the Auvi-Q has been available at retail pharmacies. Currently, patients can only receive the devices through the mail.
The Auvi-Q’s introduction to Walgreens comes as manufacturing disruptions have led to an EpiPen shortage. Drugstores across the country have no or very few EpiPens in stock. which’s especially frustrating for parents who are trying to stock up as well as send their children back to school having a fresh supply of medication.
Auvi-Q’s list cost can be $4,500 For just two auto-injectors. Kaleo, a privately held company, said eligible patients with commercial insurance, even those with high deductible plans or whose insurers don’t cover the Auvi-Q, can obtain which at no cost.
People without insurance whose household income can be less than $100,000 can get the Auvi-Q for free through an assistance program.
“We are working with insurance providers to maximize coverage of AUVI-Q for as many patients as possible,” Phil Rackliffe, general manager of Allergy as well as Pediatrics at Kaleo, said in a statement.
Mylan markets EpiPen, while Pfizer manufacturers which. Supply issues started out in May, although the school year has added more pressure to the situation. Amneal Pharmaceuticals, which makes the Adrenaclick, has also faced manufacturing issues which year. Pfizer also produces which drug.
The Food as well as Drug Administration approved a generic variation of EpiPen last month. Its producer, Teva, said which might launch the drug “inside coming months” although didn’t specify a date when announcing its approval.
Patients who can’t fill their epinephrine prescriptions can work with Walgreens pharmacists as well as their doctor to see if the Auvi-Q can be appropriate for them.
“Walgreens pharmacists continue to care for as well as work with patients as well as their prescribers to ensure they have access to the epinephrine auto-injectors they need, as well as we’re pleased to work with kaléo to help meet the demand for epinephrine auto-injectors across the country,” Walgreens President of Operations Richard Ashworth said in a statement.
contributed to which report